Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
DocCheck reports preliminary 2025 results: revenue and EBIT rise
DocCheck expects 2025 revenue of between €55.1 million and €55.4 million (previous year: €53.8 million) and EBIT of €7.8 million to €8.1 million (previous year: €6.6 million), putting EBIT above the most recently adjusted forecast. The cause is a better-than-expected business performance in the fourth quarter of 2025. Cash and cash equivalents fell to €14.5 million (previous year: €17.0 million); earnings per share cannot yet be quantified. For 2026 the company expects organic growth in an economically challenging environment. » More on finanzen.net
DocCheck reports preliminary nine-month figures: revenue and EBIT increased
The DocCheck Group generated revenue of €39.7 million in the first nine months of 2025 (previous year: €37.5 million) and an EBIT of €5.5–5.8 million (previous year: €3.5 million). The revenue forecast for 2025 remains €50.0–55.0 million, while the earnings forecast was raised from €5.0–5.5 million to €6.5–6.8 million. Liquid funds amounted to €14.9 million at the reporting date (previous year: €15.8 million); statements on earnings per share are not yet possible. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Dec 2025 | |
|---|---|---|
| Revenue | 28.77m | - |
| Gross profit | 6.39m | - |
| Net profit | 2.88m | - |
| EBITDA | 5.90m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 55.30m€ |
Number of shares | 5.07m |
52-week high/low | 15,90€ - 10,60€ |
Dividend yield | 9,26% |
Dividends TTM | 1,00€ |
Beta | 0,9 |
P/E ratio | 10,38 |
PEG ratio | 10,80 |
P/B ratio | 1,33 |
P/S ratio | 0,99 |
Company profile
Die DocCheck AG bietet Marketing-, Customer Relationship Management- und E-Commerce-Dienstleistungen für den Gesundheitssektor in Europa an. Das Unternehmen betreibt das DocCheck-Portal für den Informationsaustausch im Internet sowie Online- und E-Commerce-Services für Akteure im Gesundheitsmarkt. Darüber hinaus entwickelt und implementiert es Kommunikationsstrategien für neue und traditionelle Medien im Gesundheitswesen und Business-to-Business-Sektor und fördert Startups im Gesundheitswesen durch Seed-Finanzierung. Die DocCheck AG hat ihren Sitz in Köln, Deutschland.
| Name | DocCheck |
| CEO | Frank Nicolas Antwerpes |
| Headquarters | Cologne,
nw Germany |
| Website | |
| Sector | Information Technology |
| Industry | IT Services |
| IPO | 04/17/2020 |
| Employees | 414 |
Ticker symbols
| Exchange | Symbol |
|---|---|
XETRA | AJ91.DE |
Frankfurt | AJ91.F |
Düsseldorf | AJ91.DU |
SIX | AJ91.SW |
München | AJ91.MU |
Discover assets
Shareholders of DocCheck also invest in the following assets
